Longitudinal treatment responsiveness on plasma neurofilament light chain and glial fibrillary acidic protein levels in neuromyelitis optica spectrum disorder
Background: Neurofilament light chain (NfL) and glial fibrilliary acidic protein (GFAP) have been suggested to be biomarkers of the pathophysiological process of neuromyelitis optica spectrum disorders (NMOSD), but the relationship between the plasma levels of these molecules with disease activity a...
Guardado en:
Autores principales: | Tian-Xiang Zhang, Jing-Shan Chen, Chen Du, Pei Zeng, Huiming Zhang, Xuejiao Wang, Ye Liu, Zhenning Huang, Meng Yuan, Yu-Lin Li, Dongmei Jia, Fu-Dong Shi, Chao Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1551137cc52a4a8eac086cd78f034255 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis.
por: Mithu Storoni, et al.
Publicado: (2011) -
Efficacy and safety of tacrolimus treatment for neuromyelitis optica spectrum disorder
por: Bo Chen, et al.
Publicado: (2017) -
Extracellular vesicle concentrations of glial fibrillary acidic protein and neurofilament light measured 1 year after traumatic brain injury
por: Spencer Flynn, et al.
Publicado: (2021) -
Paraneoplastic neuromyelitis optica spectrum disorder associated with breast cancer
por: Yuan J, et al.
Publicado: (2019) -
Simultaneous new onset of neuromyelitis optica spectrum disorder in identical twins
por: Ivo Bekavac, et al.
Publicado: (2021)